National Cancer Institute Seeks Companies for Fusion Protein Research Partnership

Summary

The Department of Health and Human Services is seeking companies to collaborate on the pre-clinical and clinical development of fusion proteins for various diseases, including neoplasia, arteriosclerosis, and psoriasis. The National Cancer Institute has developed an assay system to identify receptor agonists and antagonists using fusion protein technology.